Checkmate Pharma raises $20 mln
Checkmate Pharmaceuticals said Tuesday that it raised $20 million in Series A financing from Sofinnova Ventures and venBio. Checkmate is a biopharmaceutical company aimed at developing cancer immunotherapies.
12 August 2015•3 mins read
